Repligen Announces Private Convertible Transaction of $600 M

WALTHAM, Mass., Dec. 07, 2023 -- Repligen Corporation today announced that on December 6, 2023, it entered into privately negotiated exchange and/or subscription agreements with certain holders of...

Related Keywords

Waltham , Massachusetts , United States , Germany , France , Ireland , Netherlands , Sweden , Estonia , Sondras Newman , , European Medicines Evaluation Agency , Exchange Commission , Drug Administration , Wood Capital Advisors , Exchange Transactions , Linkedin , Securities Exchange , Globenewswire Inc , Repligen Corporation , Convertible Senior Notes , New Notes , Subscription Transactions , Chief Financial Officer , Current Report , Perella Weinberg Partners , Fluid Management , Process Analytics , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Medicines Evaluation Agency , Annual Report , Quarterly Reports , Investor Relations , Markets ,